Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

MGI Tech partners with Eva Holding Group to enhance the accuracy of disease monitoring

  • MGI Tech has partnered with Eva Holding Group to improve disease monitoring accuracy using advanced genetic sequencing technology.
  • The collaboration aims to benefit oncology patients, rare diseases, and neonatal screening through a 72-hour Genome.
  • The agreement includes installing genetic sequencers to increase public access to genomic technologies and enhance cancer tracking accuracy.
  • More precise genetic sequencing improves personalized treatment options for patients.
Insights by Ground AI

77 Articles

WBOC 16WBOC 16
+75 Reposted by 75 other sources
Center

MGI Tech partners with Eva Holding Group to enhance the accuracy of disease monitoring

SÃO PAULO, Oct. 22, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing essential tools and technologies to drive innovation in the life sciences, has entered into a strategic partnership with Eva Holding Group, a Brazilian…

Read Full Article
Medical Device News MagazineMedical Device News Magazine

MGI Tech And Eva Holding Group Enhance Disease Monitoring

The initiative aims to expand Brazilian patients' access to genomics, including joint efforts in the development of the country's genetic sector

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 57% of the sources are Center
57% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Thursday, October 23, 2025.
Sources are mostly out of (0)

Similar News Topics

Technology icon

Technology

São Paulo icon

São Paulo

News
For You
SearchBlindspotLocal